praxis-text-mobile

New career pathways into ground-breaking treatments for those working in rare and untreatable cancers in Australia

Leading education provider PRAXIS Australia has partnered with Omico to deliver a ground-breaking, innovative program that will open new cancer treatment paths and clinical trial careers for Australians. Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) is a ground-breaking initiative that harnesses cutting-edge technology in precision medicine and comprehensive genomic profiling (CGP) to accelerate […]